· Company name changed to Tenbio Co., Ltd.
· Incorporated into Oracle Medical Group
· PUREFILL 200mg product launched
· Acquired Innobiz
· Attracted KRW 1 billion in investment from dermatology and plastic surgeons

· REGENBOW thread lifting product approved for product certification in Indonesia

· MOU signed with PLLA filler Dongbang Medical Co., Ltd.
· Launch of ECOFill 200mg
· Launch of ECOFill 500mg

· Registration of patent for manufacturing scaffold composition for tissue regeneration using involuntary emulsion diffusion method

· Purchase of the 2nd factory (SKV1, Seongnam-si, Gyeonggi-do)
· Patent registration of temperature-sensitive hydrogel composition for preventing tissue adhesion and its manufacturing method
· PLLA manufacturing method patent registration
· PLLA filler production and manufacturing license (export)

· Obtained ISO 13485 certification · Chong Kun Dang product development and OEM manufacturing
· Launch of biodegradable polymer PLLA filler prototype
· Development of temperature-sensitive filler technology
· Development of temperature-sensitive anti-adhesion agent technology
·Cannula A, L Chinese patent registration
·Obtained CE certification

· Purchase of a factory (Jungwon-gu, Seongnam-si,
Gyeonggi-do)
· Clean room completed (100 pyeong, 100,000 Cs)
· Venture business certification
· Acquired GMP certification · KFDA approval completed
· ULTRA-V product development and OEM manufacturing
· Polymer materials research and development
· Patent infringement dispute won (KRW 4 billion)
· Certified as a company with excellent technological capabilities (Korea Corporate Data)

· Company established in 2013
· CHAMSILL product development and medical device distribution
· Maeseon OEM product development and manufacturing sales
· Registered 5 patents and 3 designs related to L-shaped needle manufacturing method